Health ❯Healthcare ❯Medical Treatments ❯Neurology

Alzheimer's Disease

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

NHS Declines Coverage for Groundbreaking Alzheimer's Drug Due to High Costs

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety